Perrigo Company (PRGO) - FREE Research Report

Yu Louis who is Executive VP Global Quality at Perrigo Company sold 2,292 shares at $155.51 on Nov. 26, 2013. Following this transaction, the Executive VP Global Quality owned 8,548 shares meaning that the stake was reduced by 21.14% with the 2,292 share transaction.

The shares most recently traded at $156.24, up $0.73, or 0.47% since the insider transaction. Historical insider transactions for Perrigo Company go as follows:

  • 4-Week # shares sold: 455
  • 12-Week # shares sold: 2,310
  • 24-Week # shares sold: 14,666

The average volume for Perrigo Company has been 1.0 million shares per day over the past 30 days. Perrigo Company has a market cap of $14.8 billion and is part of the health care sector and drugs industry. Shares are up 50.38% year to date as of the close of trading on Tuesday.

Perrigo Company, through its subsidiaries, develops, manufactures, and distributes over-the-counter (OTC) and generic prescription (Rx) pharmaceuticals, nutritional products, and active pharmaceutical ingredients (API). The stock currently has a dividend yield of 0.23%. The company has a P/E ratio of 33.0. Currently there are 10 analysts that rate Perrigo Company a buy, no analysts rate it a sell, and 4 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on PRGO - FREE

TheStreet Quant Ratings rates Perrigo Company as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, growth in earnings per share, good cash flow from operations and expanding profit margins. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full Perrigo Company Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Data for this article provided by Zacks Investment Research
null

If you liked this article you might like

New Lifetime High Reached By MedAssets (MDAS)

MedAssets (MDAS) Reaches New Lifetime High Today

MedAssets (MDAS) Stock Gains on Sale to Pamplona Capital Management

Today MedAssets (MDAS) Hits New Lifetime High

Analysts' Actions -- Apple, Disney, Hershey and More